Douglas A. Tremblay

Hematology

10 E 102nd St
New York, NY 10029

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 150 publications

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Journal: Leukemia & lymphoma

Published: September 06, 2026

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

Journal: Leukemia

Published: June 08, 2026

Splanchnic vein thrombosis resulting from myeloproliferative neoplasm: same clot, different story?

Splanchnic vein thrombosis resulting from myeloproliferative neoplasm: same clot, different story?

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 21, 2026

Beyond symptom control in indolent systemic mastocytosis: Toward disease modification and individualized therapy.

Beyond symptom control in indolent systemic mastocytosis: Toward disease modification and individualized therapy.

Journal: The Journal of allergy and clinical immunology

Published: May 21, 2026

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

Journal: Blood advances

Published: May 18, 2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Journal: Haematologica

Published: May 04, 2026

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Journal: Blood neoplasia

Published: April 22, 2026

Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach.

Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach.

Journal: Leukemia

Published: March 20, 2026

CMML-consistent hematologic abnormalities in NHANES: Predominantly mild, non-macrocytic cytopenias.

CMML-consistent hematologic abnormalities in NHANES: Predominantly mild, non-macrocytic cytopenias.

Journal: Leukemia research

Published: March 01, 2026

Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease.

Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease.

Journal: Leukemia

Published: January 26, 2026

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

Journal: Hematological oncology

Published: January 23, 2026

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

Journal: JACC. Advances

Published: January 22, 2026

Showing 1-12 of 150

Last Updated: 09/26/2026